Breaking News

Cambrex Expands API Capabilities

Invests in generic API development and manufacturing at its Milan site

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cambrex Corporation, a manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), has made a number of investments, in both R&D and manufacturing capabilities to support the development and production of generic APIs, at its site in Paullo, Milan, Italy. The investments include the installation of development and analytical equipment to support the development of highly potent APIs (HPAPIs), as well as a new 2,800-liter hydrogenator and 1,500mm diameter...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters